Sonoma Pharmaceuticals, Inc. Common Stock (SNOA) is a publicly traded Healthcare sector company. As of May 21, 2026, SNOA trades at $1.12 with a market cap of $3.58M and a P/E ratio of -0.38. SNOA moved +4.46% today. Year to date, SNOA is -71.31%; over the trailing twelve months it is -67.48%. Its 52-week range spans $0.85 to $6.92. Rallies surfaces SNOA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes SNOA SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $1.12 |
| Market Cap | $3.58M |
| P/E Ratio | -0.38 |
| EPS | $-2.79 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.92 |
| 52-Week Low | $0.85 |
| Volume | 4.83K |
| Avg Volume | 0 |
| Revenue (TTM) | $14.29M |
| Net Income | $-2.91M |
| Gross Margin | 38.25% |
SNOA analyst coverage data. Average price target: $0.00.